Bio-Rad Labs’ COO Andrew Last disclosed the sale of 3,000 shares of company stock at $329.94 per share on September 6, for a total transaction amount of $989,815.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BIO:
- S&P announces changes to S&P 400, 600 indexes for quarterly rebalance
- Palantir, Dell Technologies, Erie Indemnity to be added to S&P 500 on 9/23
- Wells Fargo initiates Bio-Rad with an Equal Weight, $340 price target
- Bio-Rad initiated with an Equal Weight at Wells Fargo
- Bio-Rad Laboratories Welcomes New President and COO